![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MCM7 |
Gene summary for MCM7 |
![]() |
Gene information | Species | Human | Gene symbol | MCM7 | Gene ID | 4176 |
Gene name | minichromosome maintenance complex component 7 | |
Gene Alias | CDC47 | |
Cytomap | 7q22.1 | |
Gene Type | protein-coding | GO ID | GO:0000724 | UniProtAcc | C6EMX8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4176 | MCM7 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.18e-05 | 3.84e-01 | -0.0811 |
4176 | MCM7 | HTA11_347_2000001011 | Human | Colorectum | AD | 2.12e-05 | 2.92e-01 | -0.1954 |
4176 | MCM7 | HTA11_696_2000001011 | Human | Colorectum | AD | 1.39e-09 | 6.20e-01 | -0.1464 |
4176 | MCM7 | HTA11_1391_2000001011 | Human | Colorectum | AD | 3.68e-14 | 7.04e-01 | -0.059 |
4176 | MCM7 | HTA11_546_2000001011 | Human | Colorectum | AD | 1.24e-06 | 5.64e-01 | -0.0842 |
4176 | MCM7 | HTA11_866_3004761011 | Human | Colorectum | AD | 6.60e-11 | 5.40e-01 | 0.096 |
4176 | MCM7 | HTA11_6801_2000001011 | Human | Colorectum | SER | 7.03e-07 | 9.59e-01 | 0.0171 |
4176 | MCM7 | HTA11_10711_2000001011 | Human | Colorectum | AD | 3.57e-04 | 4.11e-01 | 0.0338 |
4176 | MCM7 | HTA11_7696_3000711011 | Human | Colorectum | AD | 7.81e-14 | 5.87e-01 | 0.0674 |
4176 | MCM7 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.01e-22 | 7.35e-01 | 0.294 |
4176 | MCM7 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 1.04e-17 | 7.02e-01 | 0.3859 |
4176 | MCM7 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 2.08e-08 | 7.67e-01 | 0.2585 |
4176 | MCM7 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 9.52e-07 | 4.15e-01 | 0.3005 |
4176 | MCM7 | LZE7T | Human | Esophagus | ESCC | 3.34e-13 | 9.43e-01 | 0.0667 |
4176 | MCM7 | LZE20T | Human | Esophagus | ESCC | 1.77e-04 | 2.43e-01 | 0.0662 |
4176 | MCM7 | LZE21D1 | Human | Esophagus | HGIN | 7.61e-04 | 5.40e-01 | 0.0632 |
4176 | MCM7 | LZE22D1 | Human | Esophagus | HGIN | 4.04e-04 | 2.22e-01 | 0.0595 |
4176 | MCM7 | LZE22T | Human | Esophagus | ESCC | 3.08e-06 | 9.46e-01 | 0.068 |
4176 | MCM7 | LZE24T | Human | Esophagus | ESCC | 1.89e-13 | 3.29e-01 | 0.0596 |
4176 | MCM7 | LZE21T | Human | Esophagus | ESCC | 1.18e-09 | 6.21e-01 | 0.0655 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0070849 | Colorectum | AD | response to epidermal growth factor | 23/3918 | 49/18723 | 4.18e-05 | 7.37e-04 | 23 |
GO:0071364 | Colorectum | AD | cellular response to epidermal growth factor stimulus | 21/3918 | 45/18723 | 9.94e-05 | 1.50e-03 | 21 |
GO:0009410 | Colorectum | AD | response to xenobiotic stimulus | 128/3918 | 462/18723 | 2.69e-04 | 3.31e-03 | 128 |
GO:0032392 | Colorectum | AD | DNA geometric change | 31/3918 | 90/18723 | 2.02e-03 | 1.63e-02 | 31 |
GO:00708491 | Colorectum | SER | response to epidermal growth factor | 20/2897 | 49/18723 | 1.72e-05 | 5.15e-04 | 20 |
GO:00713641 | Colorectum | SER | cellular response to epidermal growth factor stimulus | 18/2897 | 45/18723 | 6.20e-05 | 1.44e-03 | 18 |
GO:00708492 | Colorectum | MSS | response to epidermal growth factor | 20/3467 | 49/18723 | 2.36e-04 | 3.24e-03 | 20 |
GO:00713642 | Colorectum | MSS | cellular response to epidermal growth factor stimulus | 18/3467 | 45/18723 | 6.38e-04 | 6.99e-03 | 18 |
GO:00323921 | Colorectum | MSS | DNA geometric change | 29/3467 | 90/18723 | 1.26e-03 | 1.20e-02 | 29 |
GO:00094101 | Colorectum | MSS | response to xenobiotic stimulus | 110/3467 | 462/18723 | 2.36e-03 | 1.92e-02 | 110 |
GO:0006302 | Colorectum | MSS | double-strand break repair | 64/3467 | 251/18723 | 3.58e-03 | 2.65e-02 | 64 |
GO:0032508 | Colorectum | MSS | DNA duplex unwinding | 25/3467 | 84/18723 | 8.27e-03 | 4.99e-02 | 25 |
GO:00323926 | Esophagus | HGIN | DNA geometric change | 25/2587 | 90/18723 | 3.77e-04 | 5.85e-03 | 25 |
GO:007084918 | Esophagus | HGIN | response to epidermal growth factor | 16/2587 | 49/18723 | 6.14e-04 | 8.56e-03 | 16 |
GO:007136418 | Esophagus | HGIN | cellular response to epidermal growth factor stimulus | 15/2587 | 45/18723 | 7.05e-04 | 9.52e-03 | 15 |
GO:00325084 | Esophagus | HGIN | DNA duplex unwinding | 22/2587 | 84/18723 | 1.91e-03 | 2.03e-02 | 22 |
GO:00062604 | Esophagus | ESCC | DNA replication | 181/8552 | 260/18723 | 3.55e-15 | 2.05e-13 | 181 |
GO:00062612 | Esophagus | ESCC | DNA-dependent DNA replication | 100/8552 | 151/18723 | 2.61e-07 | 3.94e-06 | 100 |
GO:00063024 | Esophagus | ESCC | double-strand break repair | 152/8552 | 251/18723 | 1.33e-06 | 1.62e-05 | 152 |
GO:007084919 | Esophagus | ESCC | response to epidermal growth factor | 38/8552 | 49/18723 | 5.24e-06 | 5.49e-05 | 38 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa041109 | Esophagus | HGIN | Cell cycle | 38/1383 | 157/8465 | 6.70e-03 | 4.37e-02 | 3.47e-02 | 38 |
hsa0411016 | Esophagus | HGIN | Cell cycle | 38/1383 | 157/8465 | 6.70e-03 | 4.37e-02 | 3.47e-02 | 38 |
hsa0411023 | Esophagus | ESCC | Cell cycle | 126/4205 | 157/8465 | 1.34e-15 | 5.60e-14 | 2.87e-14 | 126 |
hsa030304 | Esophagus | ESCC | DNA replication | 32/4205 | 36/8465 | 7.71e-07 | 5.06e-06 | 2.59e-06 | 32 |
hsa0411033 | Esophagus | ESCC | Cell cycle | 126/4205 | 157/8465 | 1.34e-15 | 5.60e-14 | 2.87e-14 | 126 |
hsa0303011 | Esophagus | ESCC | DNA replication | 32/4205 | 36/8465 | 7.71e-07 | 5.06e-06 | 2.59e-06 | 32 |
hsa041104 | Liver | Cirrhotic | Cell cycle | 61/2530 | 157/8465 | 9.53e-03 | 3.21e-02 | 1.98e-02 | 61 |
hsa0411011 | Liver | Cirrhotic | Cell cycle | 61/2530 | 157/8465 | 9.53e-03 | 3.21e-02 | 1.98e-02 | 61 |
hsa041102 | Liver | HCC | Cell cycle | 106/4020 | 157/8465 | 2.54e-07 | 3.04e-06 | 1.69e-06 | 106 |
hsa041103 | Liver | HCC | Cell cycle | 106/4020 | 157/8465 | 2.54e-07 | 3.04e-06 | 1.69e-06 | 106 |
hsa041108 | Oral cavity | OSCC | Cell cycle | 118/3704 | 157/8465 | 7.15e-16 | 2.66e-14 | 1.35e-14 | 118 |
hsa03030 | Oral cavity | OSCC | DNA replication | 31/3704 | 36/8465 | 1.70e-07 | 1.19e-06 | 6.03e-07 | 31 |
hsa0411015 | Oral cavity | OSCC | Cell cycle | 118/3704 | 157/8465 | 7.15e-16 | 2.66e-14 | 1.35e-14 | 118 |
hsa030301 | Oral cavity | OSCC | DNA replication | 31/3704 | 36/8465 | 1.70e-07 | 1.19e-06 | 6.03e-07 | 31 |
hsa030302 | Oral cavity | LP | DNA replication | 23/2418 | 36/8465 | 1.08e-05 | 7.79e-05 | 5.02e-05 | 23 |
hsa0411022 | Oral cavity | LP | Cell cycle | 70/2418 | 157/8465 | 1.17e-05 | 8.27e-05 | 5.33e-05 | 70 |
hsa030303 | Oral cavity | LP | DNA replication | 23/2418 | 36/8465 | 1.08e-05 | 7.79e-05 | 5.02e-05 | 23 |
hsa0411032 | Oral cavity | LP | Cell cycle | 70/2418 | 157/8465 | 1.17e-05 | 8.27e-05 | 5.33e-05 | 70 |
hsa0411021 | Prostate | Tumor | Cell cycle | 51/1791 | 157/8465 | 5.67e-04 | 2.89e-03 | 1.79e-03 | 51 |
hsa0411031 | Prostate | Tumor | Cell cycle | 51/1791 | 157/8465 | 5.67e-04 | 2.89e-03 | 1.79e-03 | 51 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MCM7 | SNV | Missense_Mutation | novel | c.1183G>C | p.Asp395His | p.D395H | P33993 | protein_coding | tolerated(0.07) | probably_damaging(0.954) | TCGA-CQ-5326-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
MCM7 | SNV | Missense_Mutation | rs752747070 | c.328N>A | p.Glu110Lys | p.E110K | P33993 | protein_coding | tolerated(0.1) | benign(0.231) | TCGA-CR-5248-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | PD |
MCM7 | SNV | Missense_Mutation | novel | c.962N>T | p.Arg321Met | p.R321M | P33993 | protein_coding | tolerated(0.07) | benign(0.003) | TCGA-CV-6951-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
MCM7 | SNV | Missense_Mutation | rs759076249 | c.1490N>G | p.Pro497Arg | p.P497R | P33993 | protein_coding | deleterious(0.03) | probably_damaging(0.984) | TCGA-CV-7099-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MCM7 | SNV | Missense_Mutation | rs200625974 | c.592N>T | p.Pro198Ser | p.P198S | P33993 | protein_coding | tolerated(0.17) | benign(0.367) | TCGA-CV-A468-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
MCM7 | SNV | Missense_Mutation | novel | c.463N>C | p.Asp155His | p.D155H | P33993 | protein_coding | tolerated(0.09) | benign(0.428) | TCGA-HD-8634-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MCM7 | SNV | Missense_Mutation | rs770263756 | c.1441C>T | p.Arg481Cys | p.R481C | P33993 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-UF-A7JA-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MCM7 | SNV | Missense_Mutation | rs781082655 | c.1000N>A | p.Glu334Lys | p.E334K | P33993 | protein_coding | tolerated(0.08) | possibly_damaging(0.54) | TCGA-BR-8361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
MCM7 | SNV | Missense_Mutation | c.1523N>T | p.Pro508Leu | p.P508L | P33993 | protein_coding | deleterious(0) | possibly_damaging(0.875) | TCGA-CD-5801-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD | |
MCM7 | SNV | Missense_Mutation | c.335N>A | p.Arg112Gln | p.R112Q | P33993 | protein_coding | tolerated(0.16) | benign(0.018) | TCGA-CD-A4MG-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |